We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $111M
1-Year Est. Return 29.02%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+29.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$2.31M
Cap. Flow
-$3.95M
Cap. Flow %
-3.69%
Top 10 Hldgs %
50.35%
Holding
99
New
11
Increased
15
Reduced
18
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 31.8%
2 Financials 12.85%
3 Consumer Discretionary 11.11%
4 Communication Services 8.2%
5 Technology 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDXJ icon
76
VanEck Junior Gold Miners ETF
GDXJ
$8.44B
$244K 0.23%
8,903
INTC icon
77
Intel
INTC
$493B
$244K 0.23%
5,160
BTU icon
78
Peabody Energy
BTU
$2.95B
$235K 0.22%
6,594
GDX icon
79
VanEck Gold Miners ETF
GDX
$27.2B
$235K 0.22%
12,683
-6,342
-33% -$127K
WFT
80
DELISTED
Weatherford International plc
WFT
$218K 0.2%
80,401
SRRA
81
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$201K 0.19%
2,957
FOLD
82
DELISTED
Amicus Therapeutics
FOLD
$193K 0.18%
+15,972
New +$223K
SYRS
83
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$158K 0.15%
+1,327
New +$154K
ZYNE
84
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$153K 0.14%
18,792
CLF icon
85
Cleveland-Cliffs
CLF
$7.11B
$137K 0.13%
10,785
NERV icon
86
Minerva Neurosciences
NERV
$203M
$126K 0.12%
1,253
SIOX
87
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$76K 0.07%
3,915
TGTX icon
88
TG Therapeutics
TGTX
$7.56B
$70K 0.07%
+12,528
New +$143K
VIRX
89
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$70K 0.07%
+1,000
New +$75.9K
SAN icon
90
Banco Santander
SAN
$211B
$68K 0.06%
14,130
OMED
91
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$67K 0.06%
31,475
+10,972
+54% +$26.3K
EQS icon
92
Equus Total Return
EQS
$16.5M
$34K 0.03%
17,286
MTL.PR
93
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$31K 0.03%
40,129
GMO
94
DELISTED
General Moly, Inc.
GMO
$7K 0.01%
18,928
CCS icon
95
Century Communities
CCS
$1.96B
-6,469
Closed -$204K
ESI icon
96
Element Solutions
ESI
$9.21B
-11,650
Closed -$135K
GTE icon
97
Gran Tierra Energy
GTE
$320M
-2,058
Closed -$71K
RARE icon
98
Ultragenyx Pharmaceutical
RARE
$2.55B
-6,268
Closed -$482K
VWTR
99
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
-11,864
Closed -$138K

Similar funds

Kazazian Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Kazazian Asset Management held 99 positions worth $107M, down 2.1% from $109M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kazazian Asset Management withdrew a net $3.95M in Q3 2018, closing 5 positions and reducing 18 holdings. Its most notable exit was Ultragenyx Pharmaceutical, an estimated $482K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kazazian Asset Management opened a new position in Papa John's worth $1.41M.

  • Kazazian Asset Management's largest Q3 2018 buy was Papa John's: 27,500 shares worth $1.41M.
  • Kazazian Asset Management added most to DigitalBridge in Q3 2018, an estimated $1.53M increase.
  • Kazazian Asset Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.33M.
  • Kazazian Asset Management fully exited Ultragenyx Pharmaceutical in Q3 2018, selling an estimated $482K.
  • Kazazian Asset Management's ten largest holdings make up 50% of its $107M portfolio in Q3 2018.
  • Kazazian Asset Management opened 11 new positions and closed 5 in Q3 2018.
  • Kazazian Asset Management's portfolio value fell 2.1% quarter-over-quarter to $107M.

Based on Kazazian Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.